NCT03883477

Endoscopic Trigger Finger Release

Cedars-Sinai Medical Center·ClinicalTrials.gov·device·Device trialEnrolling by invitation
View on ClinicalTrials.gov
Study focus
Disease/Condition
Trigger Finger
Drug/Device/Intervention
Endoscopic Release
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Cedars-Sinai Medical Center
Location
Los Angeles, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 13, 2019
End date
Dec 01, 2021
Enrollment
24 participants
Primary outcome

Scar comparison between treatment arms, as measured by the Patient and Observer Scar Assessment Scale (POSAS)

Summary

The purpose of this study is to compare recovery, scar, and patient satisfaction after
 retrograde endoscopic trigger finger release versus the standard open surgical treatment.

ICD-10 classifications
Trigger fingerAccessory finger(s)Fused fingersAccessory thumb(s)Clubbing of fingers
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03883477
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT03883477 through Pure Global AI's free database. This phase not specified trial is sponsored by Cedars-Sinai Medical Center and is currently Enrolling by invitation. The study focuses on Trigger Finger. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.